Patients with congenital heart disease may show a coagulation defect either preoperatively or immediately following cardiopulmonary bypass. The preoperative defect may include thrombocytopenia (Hartmann, 1952) , platelet function defects (Maurer, McCue, Caul, and Still, 1972; Ekert and Sheers, 1974) , excess fibrinolysis (Gralnick, 1970) , or disseminated intravascular coagulation (Dennis, Stewart, and Conrad, 1967; Komp and Sparrow, 1970) . Recent studies have suggested that the basic defect in the preoperative cyanotic patient with tissue hypoxia and secondary polycythaemia is that of low-grade intravascular coagulation (Ihenacho, Breeze, Fletcher, and Stuart, 1973) with at least partial correction resulting from heparinization and/or venesection (Jackson, 1964; Dennis et al, 1967; Ihenacho et al, 1973; Wedemeyer and Lewis, 1973; Wedemeyer, Castaneda, Edson, and Krivit, 1973) .
In the postoperative period the haemostatic defect is also reported to be multivaried and may again include thrombocytopenia, platelet function defects, excess fibrinolysis, or disseminated intravascular coagulation, plus the additional possibility of heparin rebound. There is uncertainty regarding the therapeutic value during this period of fresh frozen plasma, coagulation factor and platelet concentrates, fibrinolytic blockade with epsilon aminocaproic acid (EACA), or the reintroduction of systemic heparinization.
A serial study has therefore been made in 42 children with congenital heart disease undergoing cardiopulmonary bypass to determine the nature of the postoperative haemostatic defect at different time intervals, to relate the coagulation abnormality to blood loss, urine output, and skin temperature, and to determine the predictive value of the preoperative and immediate postoperative coagulation profiles in relation to the subsequent development of a coagulation defect.
Patients and Methods

PATIENTS
Clinical details of the 42 children investigated from a total of 158 children undergoing cardiopulmonary bypass during the year of study are given in The following methods were used: PCV by a microhaematrocrit method and platelets by phasecontrast microscopy (Dacie and Lewis, 1968) , factors V and VIII by one-stage assays after adsorption with aluminium hydroxide (Biggs and Macfarlane, 1966; Hardisty and Ingram, 1965) , fibrinogen by the method of Ellis and Stransky (1961) , plasminogen by the method of Remmert and Cohen (1949) as modified by Alkjaersig, Fletcher, and Sherry (1959) , euglobulin lysis time (ELT) by the method of Cash and Allan (1967) , and serum FDP by the method of Merskey, Kleiner, and Johnson (1966) The mean skin temperature was found to correlate significantly with the 20-hour (or nearest time interval to death) coagulation factor levels for platelets (r = 0-55,p <001)andfactorV(r = 0-89,p <0-01) and inversely with rise in FDP (r = 0 55, P <0 01). There was no correlation with the levels of factor VIII or fibrinogen. The mean skin temperature for individual patients was 31°C or lower in each of the patients who died and above 32-8°C in each of the survivors.
EFFECT OF LENGTH OF BYPASS
The duration of bypass (including both perfusion time and the period of circulatory arrest) was significantly longer in cyanotic compared with acyanotic patients (fig 7) (table IV) . There was no significant difference in blood loss between the two groups.
HEPARIN REBOUND Eight of the 24 cyanotic patients developed excessive bleeding within two hours of transfer to intensive care and were shown to have excess circulating heparin by means of thrombin and reptilase clotting times and protamine sulphate titration; this excess was corrected with protamine sulphate. All eight patients had previously been rendered hypothermic (12-32°C) during the operation. Only one of these eight patients subsequently developed features of disseminated intravascular coagulation.
Discussion
Despite numerous studies of the haemostatic defect following cardiopulmonary bypass there is still uncertainty over the interpretation and management of the various defects which have been reported. The vogue for prophylactic fibrinolytic blockade with EACA has passed (Porter and Silver, 1968) but there is uncertainty over the potential value of coagulation factor and platelet concentrates and of heparin.
A coagulation profile performed serially during and after bypass has previously been used to study the haemostatic defect (Porter and Silver, 1968; Douglas, McNicol, Bain, and Mackey, 1966; Thurnherr, 1967; Gralnick and Fischer, 1971 ). These profiles have been performed on heterogeneous groups of patients comprising congenital and acquired heart defects, children and adults, and cyanotic and acyanotic patients. In contrast the profile obtained in the present study was confined to children with congenital defects and has revealed quantitative differences between three patient subgroups.
Previous studies have shown that the normal response following cessation of bypass is an initial fall in coagulation factor levels followed by a progressive return towards preoperative values. Factor VIII levels show minor changes only (Gralnick and Fischer, 1971 ) while fibrinogen shows a small reduction (Gralnick and Fischer, 1971) followed by rapid correction (Thurnherr, 1967; Porter and Silver, 1968) and a subsequent rebound to supranormal levels (Thurnherr, 1967; Porter and Silver, 1968; Boyd, Engelman, Beaudet, and Lackner, 1972) . Factor V levels fall further, and are still reduced by 30% in the first few postoperative hours (Douglas et al, 1966; Thurnherr, 1967; Porter and Silver, 1968; Gralnick and Fischer, 1971 ), but only occasionally fall to a level which may contribute to excessive bleeding (Gralnick and Fischer, 1971) . The increased fibrinolytic activity associated with bypass also corrects spontaneously within a few hours (Thurnherr, 1967; Porter and Silver, 1968; Gralnick and Fischer, 1971) unless there is a defect in the bypass technique (Brooks and Bahnson, 1972) . The present study showed a similar pattern to these previous reports in both the cyanotic and acyanotic patients who survived.
The cyanotic patients who survived, when compared with acyanotic patients, showed a significant reduction in factor VIII level only and this was related to the duration of bypass. The cyanotic patients who subsequently died, however, showed significantly lower mean levels for platelets, fibrinogen, and factor V than the cyanotic patients who survived. They also showed higher serum FDP levels, but the differences between mean FDP values did not reach statistical significance until 20 hours postoperatively. The cyanotic patients who survived showed FDP values ranging from normal up to 40 ,ug/ml. Four of the 12 cyanotic patients who died showed FDP values of 80 to 160 yg/ml; this was present as early as two hours postoperatively in three patients who died four hours, seven hours and 28 hours later. In a previous study (Boyd et al, 1972) an upper FDP limit of 5 6 ,tg/ml was found in uncomplicated bypass compared with values of 11-2 ,tg/ml or above in all of 10 patients who developed disseminated intravascular coagulation. The 10 patients, however, showed late onset disseminated intravascular coagulation ( 
